Zobrazeno 1 - 10
of 82
pro vyhledávání: '"A. Muggeri"'
Autor:
Francisco J. Meli, José Ingui, Federico Badano, Horacio Martinetto, Gustavo Sevlever, Alejandro Muggeri, Blanca Diez
Publikováno v:
Revista Argentina de Radiología, Vol 75, Iss 1, Pp 9-13 (2011)
Objetivo: realizar una evaluación retrospectiva respecto de la correlación entre la técnica de perfusión (PWI) por resonancia magnética (RM), el volumen sanguíneo cerebral relativo (VSCr) y el genotipo tumoral, en pacientes con neoplasias oligo
Externí odkaz:
https://doaj.org/article/564f3639d4eb4e178242f0e7a4d64fa8
Publikováno v:
Neuro Oncol
BACKGROUND Papillary tumors of the pineal region are highly unusual lesions of unknown incidence. These are neuroepithelial tumors with papillary and solid areas. There is no standardized treatment because of the difficulty to make randomized prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cba5c0cc7c7177fa4ec8398212bec467
https://europepmc.org/articles/PMC8427335/
https://europepmc.org/articles/PMC8427335/
Publikováno v:
The Neurohospitalist. 8:177-182
Background and Purpose: Although incidence rates vary, infectious, autoimmune, and neoplastic diseases can all cause chronic and subacute meningitis (CSM). We report a Latin-American, single center, CSM case series, analyzing the main clinical charac
Autor:
Mauricio F. Farez, Andrés Cervio, Juan F. Villalonga, Alejandro Muggeri, Lucas Alessandro, Rubén Mormandi, Santiago Condomí Alcorta
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 76, Iss 3, Pp 139-144
Arquivos de Neuro-Psiquiatria v.76 n.3 2018
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 76, Issue: 3, Pages: 139-144, Published: MAR 2018
Arquivos de Neuro-Psiquiatria v.76 n.3 2018
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 76, Issue: 3, Pages: 139-144, Published: MAR 2018
Background Primary central nervous system lymphomas (PCNSL) are infrequent. The traditional treatment of choice is chemotherapy. Complete resections have generally not been recommended, because of the risk of permanent central nervous system deficits
Autor:
Muggeri, Alejandro1, Vago, Miguel2, Pérez, Sebastián2, Rubio, Marcelo2, González, Cecilia2, Magariños, Cristian2, Rosenberg, Mónica2, Costa, Fernando2 fcosta@asofarma.com, Pérez-Lloret, Santiago3
Publikováno v:
Drugs in R&D. Sep2017, Vol. 17 Issue 3, p427-434. 8p.
Autor:
Florencia Yorio, Alejandro Muggeri, Naomi Arakaki, Blanca Diez, Lucas Alessandro, Roberto Nicolas Palomar, Mercedes Garcia Lombardi
Publikováno v:
Neuro-Oncology
INTRODUCTION Ewing Sarcoma (ES) is defined by molecular markers, being t(11;22)(q24;q12) the most frequent. Intracranial ES usually shows as metastases from extracranial sites. Primary central nervous system (CNS) lesions are extremely rare. MATERIAL
Autor:
Miguel Vago, Cecilia González, Cristian Magariños, Fernando Guillermo Costa, Marcelo Rubio, Alejandro Muggeri, Santiago Pérez-Lloret, Mónica Esther Rosenberg, Sebastián Ezequiel Pérez
Publikováno v:
Drugs in R&D. 17:427-434
Temozolomide is an antineoplastic agent of proven efficacy against high-grade gliomas. The objective of this crossover, single-dose, bioequivalence study was to compare the rate and extent of absorption of oral temozolomide after administration of th
Autor:
Lucas Alessandro, Florencia Yorio, Naomi Arakaki, Nicolas Palomar, Alejandro Muggeri, Blanca Diez
Publikováno v:
Neuro Oncol
INTRODUCTION Ewing Sarcoma (ES) is defined by molecular markers, being t(11,22) the most frequent. Intracranial ES/pPNET usually represent metastases from extracranial sites. Primary Central Nervous System (CNS) lesions are extremely rare. MATERIAL A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e40976d1a0cc7367f3622542dfd063c
https://europepmc.org/articles/PMC6847547/
https://europepmc.org/articles/PMC6847547/
Autor:
José N. Minatta, Lorena Lupinacci, Gonzalo Recondo, Susana Sena, Gastón Boggio, Alejandro Muggeri, Carlos Rosenbrock, Federico Cayol, Martín Ángel, Miguel Muñoz, Susana Berutti, Nicolás Castagneris, Dolores Gómez Bradley, José M. Lastiri
Publikováno v:
Oncología Clínica. 23
El osimertinib es un inhibidor irreversible de tercera generación de tirosina quinasa (ITK) del receptor del factor de crecimiento epidérmico (EGFR), y de la mutación de resistencia T790M del EGFR. Está indicado para el tratamiento de primera
Autor:
Lucas, Alessandro, José M, Pastor Rueda, Juan F, Villalonga, Verónica A, Bruno, Federico, Carpani, Juan B, Blaquier, Sofía, Tognarelli, Francisco J, Varela, Alejandro, Muggeri
Publikováno v:
Medicina. 77(1)
Primary central nervous system lymphoma (PCNSL) is an infrequent form of non-Hodgkin lymphoma restricted to the CNS. More than 90% are type B and mainly affect patients aged 50-70 years. Immunodeficiency is the most important risk factor. The aim of